NDC 53225-2001-01 - Prolaxa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53225-2001
- Requested NDC
- 53225-2001-01
- Package NDCs from labels
- 53225-2001-1, 53225-2001-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prolaxa - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-08-05 | HUMAN OTC DRUG LABEL |
| Prolaxa - Terrain Pharmaceuticals | Terrain Pharmaceuticals | 2025-06-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53225-2001-1 | Prolaxa | 100 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53225-2001 | PROLAXA (DOCUSATE SODIUM 250MG) CAPSULE, LIQUID FILLED [TERRAIN PHARMACEUTICALS] | 1 | Current NDC, 1 package rows | 20250416_32610e42-f352-09fd-e063-6394a90abff6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53225-2001-1 | EA - Each | 53225-2001 | aa1310eb-6faa-4bfc-a75f-85befacab3b4 | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | PDC6A3C0OX |
| Magnesium Citrate | MAGNESIUM CITRATE ORAL SOLUTION | Bionpharma, Inc. | 4019fbd0-fcf9-77a6-e063-6294a90a5ae7 | 2025-09-30 | Warnings | M007 |
| LEADER HYDROCORTISONE WITH ALOE | HYDROCORTISONE | LEADER | 39916470-15bf-4bd0-96e2-b909d68cf9c4 | 2025-09-29 | Warnings | M007 |
| Leader Ready to Use Mineral Oil Laxative | MINERAL OIL | Cardinal Health | b8494d02-8a7d-47b4-80b0-b8ab51b625fd | 2025-09-29 | Warnings | M007 |
| Leader Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Cardinal Health | 1b4f9c28-0547-4922-aa15-990c6fd9dc9f | 2025-09-29 | Warnings | M007 |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | PDC6A3C0OX |
| Milk of Magnesia | MAGNESIUM HYDROXIDE | Kesin Pharma Corporation | 3f7cff50-749b-5275-e063-6394a90af407 | 2025-09-23 | Warnings | M007 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Bryant Ranch Prepack | 12f613e4-c919-4cc4-a445-eb30039ae45f | 2025-09-18 | Warnings | M007 F05Q2T2JA0 |
| Saline Laxative | SALINE LAXATIVE | Major Pharmaceuticals | b3758ffe-1bac-4df6-9714-5e33e9d28d90 | 2025-09-16 | Warnings | M007 |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | PDC6A3C0OX |
| Gentle Laxative | BISACODYL | BETTER LIVING BRANDS LLC. | f29d57f6-0938-d459-e053-2995a90ad86b | 2025-09-13 | Warnings | M007 |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 |
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Oasis TEARS PF PLUS Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 5d080191-423d-4c0a-b5ae-2ccf5c4a67cb | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rising Pharma Holdings, Inc. | db539b39-9504-44d2-9bd5-ba6ffb441024 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin Children | GLYCERIN | Rising Pharma Holdings, Inc. | 80a5a944-2882-4f8d-a955-ef827cead5f0 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.